Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer

Colorectal cancer (CRC) remains the second leading cause of cancer-related mortality worldwide. While immune checkpoint inhibitors have ...

This review explores the role of biomarkers—biological indicators that can predict how a patient will respond to treatment or indicate the likely course of the ...

Overview of predictive and prognostic biomarkers and their ... - NCBI

Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer ...

Exploring prognostic biomarkers in pathological images of colorectal ...

We created the colorectal cancer risk score (CRCRS) to assess patient prognosis, visualized the pathological phenotype of the risk score using ...

Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer

Advancing personalized medicine in CRC hinges on identifying predictive biomarkers to guide treatment decisions. This comprehensive review ...

Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer

By synthesizing evidence and identifying gaps, the review offers insights into the biomarker landscape in CRC and discusses future challenges in ...

Exploring biomarkers for prognosis and neoadjuvant ... - Frontiers

We also identified genes by which CNV level can differentiate the response to nCT. The Cancer Genome Atlas database and the Clinical Proteomic Tumor Analysis ...

Special Issue : Predictive Biomarkers for Colorectal Cancer - MDPI

Although many biomarker studies have been reported to date, few validated markers have been identified. In recent years, genetic testing for RAS, BRAF, and MSI ...

Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer

Colorectal cancer (CRC) remains the second leading cause of cancer-related mortality worldwide. While immune checkpoint inhibitors have significantly ...

Predictive and prognostic biomarkers in personalized ...

In gastrointestinal cancers, biomarkers have contributed to the approval of several new targeted therapies. In colorectal cancer (CRC), various epidermal growth ...

Predictive and prognostic biomarkers with therapeutic targets in ...

right-sided colon cancer); (3) atypical BRAF mutations; (4) use of EGFR directed therapy in the perioperative oligometastatic disease setting; (5) re-challenge ...

Predictive and prognostic biomarkers in gastrointestinal tract tumours

This review explored current and future molecular and immunohistochemical biomarkers of GIT tumours. It also highlighted the need for further studies, as tumour ...

Prognostic and Predictive Biomarkers in Patients with Metastatic ...

Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib ... To explore the molecular mechanisms underlying ...

Biomarkers in Colorectal Cancer: The Role of Translational ...

Despite the cited potential prognostic biomarkers (Table 3), carcinoembryonic antigen remains the only established protein biomarker in clinical practice to ...

To explore the prognostic characteristics of colon cancer based on ...

Tertiary lymphoid structure (TLS) affects cancer progression by regulating immune microenvironment. Mining COAD biomarkers based on TLS-related ...

Colorectal cancer genomic biomarkers in the clinical management ...

Finally, the consensus molecular subtypes classification of CRC based on gene expression profiling has prognostic and predictive implications.

Predictive and prognostic biomarkers with therapeutic targets in ...

right-sided colon cancer); (3) atypical BRAF mutations; (4) use of EGFR directed therapy in the perioperative oligometastatic disease setting; ( ...

Dynamic liquid biopsy components as predictive and prognostic ...

Colorectal cancer (CRC) is one of the most common cancers worldwide. The diagnosis, prognosis and therapeutic monitoring of CRC depends ...

[PDF] Personalized Medicine—Current and Emerging Predictive ...

This review addresses recent data on biological prognostic and predictive biomarkers in CRC and identifies patient cohorts most likely to benefit from ...

Tumor biomarkers for diagnosis, prognosis and targeted therapy

Squamous cell carcinoma antigen (SCCA), a tumor-specific antigen, was first isolated from cervical SCC tissue by Kato and Torigoe in the 1970s.